Integrating Single-Cell Sequencing and Proteomics to Unravel Stem Cell Heterogeneity: Implications for Precision Regenerative Medicine

Stem cell populations are inherently diverse, consisting of distinct subtypes with unique molecular signatures, self-renewal capacities, and differentiation potentials. This natural variability complicates their clinical use, leading to unpredictable treatment outcomes and safety concerns in regenerative medicine. Traditional bulk analysis methods obscure this vital cellular diversity by providing average data. Therefore, studying stem cell heterogeneity at the single-cell level is crucial for developing reliable and precise therapeutic strategies. This review examines how integrating single-cell sequencing with proteomics technologies enhances the current understanding of stem cell biology. We discuss how single-cell RNA sequencing reveals transcriptomic diversity, identifies rare subpopulations, and traces lineage pathways. Additionally, we highlight emerging single-cell proteomic techniques, such as mass cytometry and high-sensitivity mass spectrometry, which directly analyze functional protein expression and signaling networks that ultimately define cellular phenotypes. Combining these methods provides a comprehensive view of stem cell states, offering insights into the molecular mechanisms that influence fate decisions and responses to external signals. Ultimately, these advances enable precision regenerative medicine by improving cell characterization and developing tailored differentiation strategies for safe and effective clinical applications.